The American Diabetes Association (ADA) has set glucose and A1C targets to help monitor glycemic control and reduce diabetes related outcomes.
Glycemic Targets1
Glucose: | < 130 mg/dl (or < 180 mg/dl two hours post meal) |
AIC: | < 7% (Patients are considered pre-diabetic if A1C is > 5.6%.) |
![]() |
A periodic finger stick glucose is not always reliably timed or performed, and may yield inaccurate results.3,4 |
![]() |
A quarterly or bi-annual A1C glucose average is a lagging indicator of glycemic control and is incapable of detecting recent hyperglycemia and glycemic variability.
|
ABNORMAL GlycoMark results identify patients with recent hyperglycemic excursions that are not evident with A1C.
INCREASING or DECREASING GlycoMark results reveal changes in glycemic control (improving or worsening).
Multiple studies independently link 1,5-AG with diabetes complications and outcomes.
Refer to the GlycoMark test package insert for additional information.
Note:
References:
1American Diabetes Association. Diabetes Care 2015 Jan; 38(Supplement 1): S33-S40.
2Stratton IM, et al. BMJ. 2000 Aug 12;321(7258):405-12.
3Erbach M, et al. J Diabetes Sci Technol. 2016;10:1161-1168.
4Klonoff DC, et al. J Diabetes Sci Technol. 2011;5:1529-1548.
5Erlinger TP, Branca FL. Diabetes Care. 2001 Oct;24(10):1734-8.
6Bonora E, et al. Diabetologia. 2006 May;49(5):846-54.
7Dungan KM, et al. Diabetes Care 2006 Jun; 29(6): 1214-1219.
8Selvin E, et al. Clin Chem. 2014 Nov; 60(11): 1409–1418.
9Selvin E, et al. Diabetes 2016;65:201–208.
10Lee AK, et al. Diabetes Care 2017 Dec; 40(12): 1661-1667.
11Rawlings AM, et al. Diabetes Care 2017 Jul; 40(7): 879-886.
12Nowak N, et al. Diabetologia 2013 Apr;56(4): 709–713.